December 27, 2024 08:16 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
I have lost a mentor and guide: Rahul Gandhi writes on Manmohan Singh's demise | Manmohan Singh left strong imprint on our economic policy over years: PM Modi | A rare leader who spoke softly but achieved monumental strides: Gautam Adani mourns Manmohan Singh's death | Instagram influencer and freelance RJ Simran Singh dies by suicide in Gurugram | Anna University sexual assault case: Accused is a DMK worker, claims BJP's Annamalai | Celebrities too responsible for crowd control: Telangana CM Revanth Reddy to Telugu filmdom amid Pushpa 2 stampede row | Boat capsizes off Calangute Beach in Goa; 1 killed, 20 rescued | Canada announces change to immigration system, likely to impact Indians seeking permanent residence | Azerbaijan Airlines tragedy: 32 passengers rescued, flight attempted several emergency landing before crashing | Man sets himself on fire near Parliament building; locals, police rush him to hospital
Hetero’s Covid-19 oral drug 'Paxlovid' to receive WHO prequalification

Hetero’s Covid-19 oral drug 'Paxlovid' to receive WHO prequalification

Dec 26, 2022, at 08:21 pm

Hyderabad/Kolkata: Hetero, a pharmaceutical company, on Monday announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir.

Hetero launches Favipiravir in India to treat mild to moderate Covid-19

Hetero launches Favipiravir in India to treat mild to moderate Covid-19

Jul 29, 2020, at 09:04 pm

Kolkata/IBNS: Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs, has announced the launch of generic Favipiravir in India under the brand name ‘Favivir' to treat mild to moderate Covid-19.